Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company leveraging artificial intelligence, was featured in the latest episode of The BioMedWire Podcast. CEO and Co-Founder Dr. Meesha Dogan discussed the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics, and AI.
During the interview, Dogan highlighted the company’s expansion into India through partnerships with Aimil Ltd. and Dr. Lal PathLabs, a move that broadens access to Cardio Diagnostics’ innovative tests in one of the world’s most populous countries. The India expansion aligns with the company’s goal to make cardiovascular disease prevention, detection, and management more accessible globally.
Dogan also provided updates on the company’s progress through the Medicare reimbursement process, noting that CPT coding and payment steps have been completed while coverage determination remains underway. This milestone is critical for Cardio Diagnostics as it seeks to secure reimbursement for its tests, which could significantly expand patient access and adoption.
Cardio Diagnostics is an AI-powered precision cardiovascular medicine company that develops clinical tests using its proprietary AI-driven Integrated Genetic-Epigenetic Engine. The company aims to become a leading medical technology company focused on improving prevention, detection, and treatment of cardiovascular disease, which remains the leading cause of death globally.
The podcast appearance comes as Cardio Diagnostics continues to advance its commercial strategy, targeting both U.S. and international markets. The partnerships in India represent a key step in international expansion, leveraging local expertise to distribute the company’s tests.
For more information on Cardio Diagnostics, visit the company’s newsroom at https://ibn.fm/CDIO. The full press release is available at https://ibn.fm/8DJcl.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Cardio Diagnostics CEO Discusses Growth Strategy and India Expansion on BioMedWire Podcast.